Erste Asset Management’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112K | Hold |
40,000
| – | – | ﹤0.01% | 818 |
|
|
2025
Q1 | $68.4K | Hold |
40,000
| – | – | ﹤0.01% | 503 |
|
|
2024
Q4 | $64.4K | Hold |
40,000
| – | – | ﹤0.01% | 512 |
|
|
2024
Q3 | $171K | Hold |
40,000
| – | – | ﹤0.01% | 486 |
|
|
2024
Q2 | $216K | Hold |
40,000
| – | – | ﹤0.01% | 476 |
|
|
2024
Q1 | $400K | Hold |
40,000
| – | – | 0.01% | 444 |
|
|
2023
Q4 | $174K | Hold |
40,000
| – | – | ﹤0.01% | 485 |
|
|
2023
Q3 | $160K | Hold |
40,000
| – | – | ﹤0.01% | 488 |
|
|
2023
Q2 | $236K | Hold |
40,000
| – | – | ﹤0.01% | 478 |
|
|
2023
Q1 | $124K | Hold |
40,000
| – | – | ﹤0.01% | 523 |
|
|
2022
Q4 | $152K | Hold |
40,000
| – | – | ﹤0.01% | 522 |
|
|
2022
Q3 | $223K | Hold |
40,000
| – | – | 0.01% | 490 |
|
|
2022
Q2 | $250K | Hold |
40,000
| – | – | 0.01% | 493 |
|
|
2022
Q1 | $326K | Buy |
+40,000
| New | +$326K | 0.01% | 474 |
|